These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37035273)

  • 1. Polymorphism of genes encoding drug-metabolizing and inflammation-related enzymes for susceptibility to cholangiocarcinoma in Thailand.
    You G; Zeng L; Tanaka H; Ohta E; Fujii T; Ohshima K; Tanaka M; Hamajima N; Viwatthanasittiphong C; Muangphot M; Chenvidhya D; Jedpiyawongse A; Sripa B; Miwa M; Honjo S
    World J Gastrointest Pathophysiol; 2023 Mar; 14(2):21-33. PubMed ID: 37035273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Asian Pac J Cancer Prev; 2011; 12(5):1341-5. PubMed ID: 21875294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
    Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
    J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Cancer Epidemiol; 2012 Apr; 36(2):e89-94. PubMed ID: 22189445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand.
    Honjo S; Srivatanakul P; Sriplung H; Kikukawa H; Hanai S; Uchida K; Todoroki T; Jedpiyawongse A; Kittiwatanachot P; Sripa B; Deerasamee S; Miwa M
    Int J Cancer; 2005 Dec; 117(5):854-60. PubMed ID: 15957169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and transcriptional alterations of cholangiocarcinoma.
    Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
    Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
    Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.
    Hung HC; Chuang J; Chien YC; Chern HD; Chiang CP; Kuo YS; Hildesheim A; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):901-5. PubMed ID: 9367063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.
    Manwong M; Songserm N; Promthet S; Matsuo K
    Asian Pac J Cancer Prev; 2013; 14(10):5953-6. PubMed ID: 24289607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis.
    Steele JA; Richter CH; Echaubard P; Saenna P; Stout V; Sithithaworn P; Wilcox BA
    Infect Dis Poverty; 2018 May; 7(1):44. PubMed ID: 29769113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand.
    Srivatanakul P; Honjo S; Kittiwatanachot P; Jedpiyawongse A; Khuhaprema T; Miwa M
    Asian Pac J Cancer Prev; 2010; 11(4):985-8. PubMed ID: 21133611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
    Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
    Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CagA
    Dangtakot R; Intuyod K; Chamgramol Y; Pairojkul C; Pinlaor S; Jantawong C; Pongking T; Haonon O; Ma N; Pinlaor P
    Helicobacter; 2021 Aug; 26(4):e12817. PubMed ID: 34031944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin suppresses eosinophils and Th17 cells in hamsters treated with a combination of human liver fluke infection and a chemical carcinogen.
    Wongsena W; Charoensuk L; Dangtakot R; Pinlaor P; Intuyod K; Pinlaor S
    Pharmacol Rep; 2018 Feb; 70(1):98-105. PubMed ID: 29331794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P; Pinlaor S; Loilome W
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of Opisthorchis viverrini-related cholangiocarcinoma.
    Jusakul A; Kongpetch S; Teh BT
    Curr Opin Gastroenterol; 2015 May; 31(3):258-63. PubMed ID: 25693006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgG as a Marker for
    Titapun A; Techasen A; Sa-Ngiamwibool P; Sithithaworn P; Luvira V; Srisuk T; Jareanrat A; Dokduang H; Loilome W; Thinkhamrop B; Khuntikeo N
    Int J Gen Med; 2020; 13():1271-1283. PubMed ID: 33273846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Profiling of Praziquantel-mediated Prevention of
    Prommajun P; Phetcharaburanin J; Namwat N; Klanrit P; Sa-Ngiamwibool P; Thanee M; Dokduang H; Kittirat Y; Li JV; Loilome W
    Cancer Genomics Proteomics; 2021; 18(1):29-42. PubMed ID: 33419894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.